Vascular dysfunction and arterial hypertension in experimental celiac disease are mediated by gut-derived inflammation and oxidative stress
Karin Keppeler,
Aline Pesi,
Simon Lange,
Johanna Helmstädter,
Lea Strohm,
Henning Ubbens,
Marin Kuntić,
Ivana Kuntić,
Dominika Mihaliková,
Ksenija Vujačić-Mirski,
Alexandra Rosenberger,
Leonie Küster,
Charlotte Frank,
Matthias Oelze,
Stefanie Finger,
Agnieszka Zakrzewska,
Elena Verdu,
Johannes Wild,
Susanne Karbach,
Philip Wenzel,
Philipp Wild,
David Leistner,
Thomas Münzel,
Andreas Daiber,
Detlef Schuppan,
Sebastian Steven
Affiliations
Karin Keppeler
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Aline Pesi
Institute of Translational Immunology (TIM), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Simon Lange
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Johanna Helmstädter
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Lea Strohm
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Henning Ubbens
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Marin Kuntić
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Ivana Kuntić
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Dominika Mihaliková
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Ksenija Vujačić-Mirski
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Alexandra Rosenberger
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Leonie Küster
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Charlotte Frank
Institute of Translational Immunology (TIM), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Matthias Oelze
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Stefanie Finger
Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
Agnieszka Zakrzewska
Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland
Elena Verdu
Farncombe Digestive Disease Center, McMaster University, Hamilton, Canada
Johannes Wild
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
Susanne Karbach
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
Philip Wenzel
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
Philipp Wild
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
David Leistner
German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany; Division of Cardiology, Goethe University Frankfurt, University Hospital, Department of Medicine III, Frankfurt a. M., Germany
Thomas Münzel
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
Andreas Daiber
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz/Frankfurt a. M., Germany
Detlef Schuppan
Institute of Translational Immunology (TIM), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Sebastian Steven
Center for Cardiology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Division of Cardiology, Goethe University Frankfurt, University Hospital, Department of Medicine III, Frankfurt a. M., Germany; Corresponding author. Department of Medicine III, Division of Cardiology, University Hospital Frankfurt a. Main, Theodor-Stern-Kai 7, 60590, Frankfurt a. Main, Germany.
Aims: We examined the cardiovascular effects of celiac disease (CeD) in a humanized mouse model, with a focus on vascular inflammation, endothelial dysfunction, and oxidative stress. Methods and results: NOD.DQ8 mice genetically predisposed to CeD were subjected to a diet regime and oral gavage to induce the disease (gluten group vs. control). We tested vascular function, confirmed disease indicators, and evaluated inflammation and oxidative stress in various tissues. Plasma proteome profiling was also performed.CeD markers were confirmed in the gluten group, indicating increased blood pressure and impaired vascular relaxation. Pro-inflammatory genes were upregulated in this group, with increased CD11b+ myeloid cell infiltration and oxidative stress parameters observed in aortic and heart tissue. However, heart function remained unaffected. Plasma proteomics suggested the cytokine interleukin-17A (IL-17A) as a link between gut and vascular inflammation. Cardiovascular complications were reversed by adopting a gluten-free diet. Conclusion: Our study sheds light in the heightened cardiovascular risk associated with active CeD, revealing a gut-to-cardiovascular inflammatory axis potentially mediated by immune cell infiltration and IL-17A. These findings augment our understanding of the link between CeD and cardiovascular disease providing clinically relevant insight into the underlying mechanism. Furthermore, our discovery that cardiovascular complications can be reversed by a gluten-free diet underscores a critical role for dietary interventions in mitigating cardiovascular risks associated with CeD.